Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Care Facilities

Surgery Partners, Inc. operates as a healthcare services company. The Company owns and manages surgical facilities, physician-partnered hospitals, diagnostic laboratory, as well as offers anesthesia, pharmacy, ancillary, and optical services throughout the United States.
Website: surgerypartners.com



Growth: Pretty weak revenue growth rate 8.5%, there is slowdown compared to average historical growth rates 14.7%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is positive, +16.1%. On average the margin is decreasing unsteadily. Gross margin is normal, +24.6%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of +$0.01 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 17.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 10.5% higher than minimum and 63.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.9x by EV / Sales multiple , the company can be 15.9% undervalued

Insiders: For the last 3 months insiders sold company shares on $1.7 mln (-0.042% of cap.)

Key Financials (Download financials)

Ticker: SGRY
Share price, USD:  (-0.8%)24.64
year average price 32.88  


year start price 39.66 2023-04-28

max close price 45.09 2023-06-29

min close price 22.32 2023-10-30

current price 24.64 2024-04-26
Common stocks: 125 747 000

Dividend Yield:  0.0%
FCF Yield LTM: 17.9%
EV / LTM EBITDA: 15.7x
EV / EBITDA annualized: 15.5x
Last revenue growth (y/y):  8.5%
Last growth of EBITDA (y/y):  6.7%
Historical revenue growth:  14.7%
Historical growth of EBITDA:  29.1%
EV / Sales: 2.5x
Margin (EBITDA LTM / Revenue): 16.1%
Fundamental value created in LTM:
Market Cap ($m): 3 098
Net Debt ($m): 3 780
EV (Enterprise Value): 6 878
Price to Book: 1.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-18GlobeNewsWire

Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details

2024-03-20Zacks Investment Research

Surgery Partners (SGRY) Upgraded to Buy: What Does It Mean for the Stock?

2024-02-28Zacks Investment Research

Wall Street Analysts Believe Surgery Partners (SGRY) Could Rally 39.04%: Here's is How to Trade

2024-02-26Zacks Investment Research

Here's What Key Metrics Tell Us About Surgery Partners (SGRY) Q4 Earnings

2024-02-26Zacks Investment Research

Surgery Partners (SGRY) Beats Q4 Earnings Estimates

2024-02-21Zacks Investment Research

Gear Up for Surgery Partners (SGRY) Q4 Earnings: Wall Street Estimates for Key Metrics

2024-02-05Zacks Investment Research

Why Surgery Partners (SGRY) is Poised to Beat Earnings Estimates Again

2024-01-16MarketBeat

Surgery Partners feeling no pinch from macroeconomic weakness

2024-01-05GlobeNewsWire

Surgery Partners, Inc. to Present at Upcoming Investor Conference

2023-11-06Zacks Investment Research

Surgery Partners (SGRY) Soars 9.9%: Is Further Upside Left in the Stock?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol SGRY SGRY SGRY SGRY SGRY SGRY
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-26 2023-11-07 2023-08-01 2023-05-02 2023-03-01 2022-11-08
acceptedDate 2024-02-26 16:45:06 2023-11-07 16:38:42 2023-08-01 16:32:24 2023-05-02 08:02:45 2023-03-01 09:46:13 2022-11-08 16:55:27
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 735M 674M 668M 666M 707M 621M
costOfRevenue 573M 508M 514M 532M 523M 489M
grossProfit 163M 166M 154M 134M 184M 131M
grossProfitRatio 0.221 0.246 0.231 0.201 0.261 0.211
researchAndDevelopmentExpenses 0 0 0 0 0 0
generalAndAdministrativeExpenses 21M 109M 31M 32M 29M 18M
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 21M 109M 31M 32M 29M 18M
otherExpenses -33M 0 0 33M 29M 29M
operatingExpenses 21M 109M 54M 65M 58M 47M
costAndExpenses 594M 618M 568M 597M 581M 537M
interestIncome -144M 50M 0 0 0 0
interestExpense 60M -50M 48M 47M 61M 61M
depreciationAndAmortization 31M 29M 24M 34M 30M -11M
ebitda 173M 12M 127M 106M 170M 73M
ebitdaratio 0.235 0.018 0.190 0.159 0.240 0.118
operatingIncome 142M 83M 98M 72M 140M 84M
operatingIncomeRatio 0.193 0.123 0.146 0.109 0.198 0.135
totalOtherIncomeExpensesNet -89M -50M -2M -73M -107M -71M
incomeBeforeTax 53M 33M 50M -400 000 33M 13M
incomeBeforeTaxRatio 0.072 0.049 0.075 -0.001 0.047 0.022
incomeTaxExpense 6M -3M -8M -2M 10M 8M
netIncome -1 000 000 36M 19M 1M 23M 6M
netIncomeRatio -0.001 0.053 0.028 0.002 0.033 0.009
eps -0.008 0.290 0.150 0.010 0.230 0.063
epsdiluted -0.008 0.290 0.150 0.010 0.230 0.063
weightedAverageShsOut 126M 126M 126M 125M 102M 89M
weightedAverageShsOutDil 126M 126M 127M 125M 102M 89M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol SGRY SGRY SGRY SGRY SGRY SGRY
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-26 2023-11-07 2023-08-01 2023-05-02 2023-03-01 2022-11-08
acceptedDate 2024-02-26 16:45:06 2023-11-07 16:38:42 2023-08-01 16:32:24 2023-05-02 08:02:45 2023-03-01 09:46:13 2022-11-08 16:55:27
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 196M 236M 177M 246M 283M 155M
shortTermInvestments 0 0 0 0 0 0
cashAndShortTermInvestments 196M 236M 177M 246M 283M 155M
netReceivables 514M 463M 450M 453M 456M 422M
inventory 75M 69M 70M 72M 71M 69M
otherCurrentAssets 110M 108M 633M 99M 79M 93M
totalCurrentAssets 895M 876M 810M 869M 921M 738M
propertyPlantEquipmentNet 1 224M 1 184M 1 093M 1 118M 1 156M 1 151M
goodwill 4 326M 4 245M 0 0 4 137M 0
intangibleAssets 55M 56M 0 0 42M 0
goodwillAndIntangibleAssets 4 381M 4 301M 4 291M 4 253M 4 179M 4 187M
longTermInvestments 259M 196M 192M 192M 190M 189M
taxAssets 232M 105M 106M 93M 92M 103M
otherNonCurrentAssets 29M 117M 128M 119M 144M 169M
totalNonCurrentAssets 6 124M 5 904M 5 810M 5 774M 5 761M 5 798M
otherAssets 0 0 0 0 0 0
totalAssets 7 019M 6 780M 6 621M 6 643M 6 682M 6 537M
accountPayables 177M 149M 132M 144M 152M 138M
shortTermDebt 111M 62M 65M 63M 99M 154M
taxPayables 0 0 0 0 0 0
deferredRevenue -245M 0 -196M 0 3M 8M
otherCurrentLiabilities 480M 291M 459M 268M 239M 324M
totalCurrentLiabilities 523M 501M 459M 475M 493M 624M
longTermDebt 2 034M 2 881M 2 505M 2 800M 2 830M 3 372M
deferredRevenueNonCurrent 917M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 142M 0 0 0 92M 0
otherNonCurrentLiabilities 41M 1 393M 983M 1 407M -16M 3 168M
totalNonCurrentLiabilities 3 134M 4 274M 3 488M 4 206M 2 906M 3 468M
otherLiabilities 0 2 005M 0 -4 206M 3 283M 0
capitalLeaseObligations 917M 241M 264M 269M 308M 307M
totalLiabilities 3 657M 6 780M 3 946M 475M 6 682M 4 092M
preferredStock 510M 0 483M 0 0 0
commonStock 1M 1M 1M 160 000 1M 900 000
retainedEarnings -569M -568M -563M -582M -557M -534M
accumulatedOtherComprehensiveIncomeLoss 58M 77M 79M 65M 76M 83M
othertotalStockholdersEquity 1 987M 2 495M 2 018M 2 479M 2 478M 1 623M
totalStockholdersEquity 1 987M 2 005M 2 018M 1 962M 1 998M 1 173M
totalEquity 3 362M 3 319M 2 674M 2 654M 1 998M 1 173M
totalLiabilitiesAndStockholdersEquity 7 019M 8 785M 6 621M 6 643M 6 682M 5 265M
minorityInterest 1 375M 1 314M 656M 692M 1 285M 0
totalLiabilitiesAndTotalEquity 7 019M 8 785M 6 621M 6 643M 6 682M 5 265M
totalInvestments 259M 196M 192M 192M 190M 189M
totalDebt 3 062M 2 943M 2 570M 2 863M 2 930M 3 526M
netDebt 2 866M 2 707M 2 392M 2 617M 2 647M 3 371M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol SGRY SGRY SGRY SGRY SGRY SGRY
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-26 2023-11-07 2023-08-01 2023-05-02 2023-03-01 2022-11-08
acceptedDate 2024-02-26 16:45:06 2023-11-07 16:38:42 2023-08-01 16:32:24 2023-05-02 08:02:45 2023-03-01 09:46:13 2022-11-08 16:55:27
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome -1 000 000 6M -9M -26M 23M 6M
depreciationAndAmortization 31M 29M 24M 34M 30M 30M
deferredIncomeTax 9M 700 000 8M -2M 10M 8M
stockBasedCompensation 5M 4M 5M 4M 5M 5M
changeInWorkingCapital -66M 22M 48M 9M -90M -37M
accountsReceivables -29M -13M -14M 9M -39M -2M
inventory 0 0 0 0 0 0
accountsPayables 0 0 0 0 0 0
otherWorkingCapital -37M 35M 61M -9M -51M -35M
otherNonCashItems 85M 43M -23M 56M 29M 18M
netCashProvidedByOperatingActivities 63M 105M 52M 75M 7M 30M
investmentsInPropertyPlantAndEquipment -20M -19M -26M -24M -23M -17M
acquisitionsNet -31M -6M -3M -41M -63M -37M
purchasesOfInvestments -100 000 -2M -39M -10M -29M 0
salesMaturitiesOfInvestments 400 000 1 000 000 0 0 1M 0
otherInvestingActivites -7M 200 000 -4M 4M 41M 0
netCashUsedForInvestingActivites -58M -26M -71M -71M -72M -54M
debtRepayment -16M -76M -16M -16M -781M -48M
commonStockIssued 0 0 0 0 883M 0
commonStockRepurchased 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites -29M 55M -33M -25M 91M 200 000
netCashUsedProvidedByFinancingActivities -45M -20M -49M -41M 193M -48M
effectOfForexChangesOnCash 330M -24M -23M -283M 0 0
netChangeInCash -40M -143M -92M -320M 128M -73M
cashAtEndOfPeriod 196M 35M -120M -37M 283M 155M
cashAtBeginningOfPeriod 236M 177M -29M 283M 155M 227M
operatingCashFlow 63M 105M 52M 75M 7M 30M
capitalExpenditure -20M -19M -26M -24M -23M -17M
freeCashFlow 43M 86M 26M 50M -16M 12M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-26 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-01 ET (fiscal 2023 q2)
2023 q1
2023-05-01 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2022-11-12 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-26 12:30 ET
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance
2024-02-08 21:05 ET
Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
2024-01-08 12:30 ET
Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook
2024-01-05 18:40 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2023-12-14 21:33 ET
Surgery Partners, Inc. Announces Proposed Secondary Offering of Common Stock
2023-12-06 14:17 ET
Surgery Partners, Inc. Completes Refinancing Transaction
2023-11-07 12:30 ET
Surgery Partners, Inc. Announces Third Quarter 2023 Results
2023-10-06 19:29 ET
Surgery Partners, Inc. Announces Third Quarter 2023 Earnings Release Date and Conference Call Details
2023-09-20 12:05 ET
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
2023-08-01 11:30 ET
Surgery Partners, Inc. Announces Second Quarter 2023 Results
2023-07-20 00:32 ET
Surgery Partners, Inc. Announces Second Quarter 2023 Earnings Release Date and Conference Call Details
2023-05-01 20:01 ET
Surgery Partners, Inc. Announces First Quarter 2023 Results
2023-04-19 10:00 ET
Surgery Partners, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call Details
2023-03-01 12:40 ET
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance
2023-02-09 21:15 ET
Surgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call Details
2023-01-09 12:30 ET
Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance
2023-01-03 21:10 ET
Surgery Partners, Inc. To Present At Upcoming Investor Conference
2022-11-21 14:52 ET
Surgery Partners, Inc. Announces Pricing of Upsized $575 Million Public Offering of Common Stock and $225 Million Concurrent Private Placement to Bain Capital
2022-11-21 11:00 ET
Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock
2022-11-08 12:40 ET
Surgery Partners, Inc. Announces Third Quarter 2022 Results
2022-10-10 20:23 ET
Surgery Partners, Inc. Announces Third Quarter 2022 Earnings Release Date and Conference Call Details
2022-08-02 11:30 ET
Surgery Partners, Inc. Announces Second Quarter 2022 Results
2022-06-29 20:15 ET
Surgery Partners, Inc. Announces Second Quarter 2022 Earnings Release Date and Conference Call Details
2022-06-02 20:50 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2022-05-04 22:19 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
2022-05-03 13:00 ET
Surgery Partners, Inc. And ValueHealth, LLC Announce Strategic Partnership
2022-05-03 13:00 ET
SURGERY PARTNERS, INC. AND VALUEHEALTH, LLC ANNOUNCE STRATEGIC PARTNERSHIP
2022-05-03 11:30 ET
Surgery Partners, Inc. Announces First Quarter 2022 Results
2022-04-07 20:30 ET
Surgery Partners, Inc. Announces First Quarter 2022 Earnings Release Date and Conference Call Details
2022-02-28 21:07 ET
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2021 Results; Raises 2022 Guidance
2022-02-04 12:30 ET
Surgery Partners, Inc. Announces Fourth Quarter 2021 Earnings Release Date and Conference Call Details
2022-01-10 12:30 ET
Surgery Partners Reaffirms 2021 and 2022 Full Year Guidance; David T. Doherty to Assume Role of Chief Financial Officer on February 1, 2022
2022-01-03 19:00 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2021-11-15 13:00 ET
Surgery Partners, Inc. Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
2021-11-09 13:20 ET
Surgery Partners, Inc. Announces Pricing of $279.0 million Public Offering of Common Stock
2021-11-08 12:00 ET
Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock
2021-11-02 20:15 ET
Surgery Partners, Inc. Announces Third Quarter 2021 Results
2021-10-14 20:16 ET
Surgery Partners, Inc. Announces Third Quarter 2021 Earnings Release Date and Conference Call Details
2021-08-04 11:00 ET
Surgery Partners, Inc. Announces Second Quarter 2021 Results
2021-07-09 14:12 ET
Surgery Partners, Inc. Announces Second Quarter 2021 Earnings Release Date and Conference Call Details
2021-05-28 19:09 ET
Surgery Partners, Inc. and UCI Health Announce New Strategic Partnership
2021-05-26 01:12 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2021-05-10 15:47 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
2021-05-05 11:00 ET
Surgery Partners, Inc. Announces First Quarter 2021 Results; Completes Refinancing Transactions
2021-04-20 11:45 ET
Surgery Partners, Inc. Announces Term Loan Refinancing and Conversion of Preferred Stock; Provides Preliminary First Quarter 2021 Financial Performance Update
2021-04-06 14:16 ET
Surgery Partners, Inc. Announces First Quarter 2021 Earnings Release Date and Conference Call Details
2021-03-10 12:00 ET
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2020 Results
2021-03-01 22:36 ET
Surgery Partners, Inc. Names Patricia A. Maryland, Dr to Board of Directors
2021-02-19 19:48 ET
Surgery Partners, Inc. Announces Fourth Quarter 2020 Earnings Release Date and Conference Call Details
2021-01-28 14:05 ET
Surgery Partners, Inc. Announces Pricing of $226.9 Million Public Offering of Common Stock
2021-01-25 21:39 ET
Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock
2021-01-11 12:30 ET
Surgery Partners, Inc. Reaffirms 2020 Adjusted EBITDA Guidance and Provides 2021 Initial Adjusted EBITDA Outlook
2020-12-28 20:04 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2020-11-18 20:05 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2020-11-04 12:00 ET
Surgery Partners, Inc. Announces Third Quarter 2020 Results
2020-10-21 16:26 ET
Surgery Partners, Inc. Announces Third Quarter 2020 Earnings Release Date and Conference Call Details
2020-09-15 21:30 ET
NorthStar Anesthesia Completes Acquisition of Surgery Partners Anesthesia Services Business
2020-08-05 11:00 ET
Surgery Partners, Inc. Announces Second Quarter 2020 Results
2020-07-24 13:39 ET
Surgery Partners, Inc. Announces Pricing of Incremental Note Offering
2020-07-21 15:21 ET
Surgery Partners, Inc. Announces Second Quarter 2020 Earnings Release Date and Conference Call Details
2020-05-11 20:01 ET
Surgery Partners, Inc. Announces First Quarter 2020 Results
2020-05-08 21:33 ET
Surgery Partners Announces Change in Annual Meeting Location to Virtual Format
2020-05-01 12:30 ET
Surgery Partners, Inc. Announces First Quarter 2020 Earnings Release Date and Conference Call Details
2020-03-05 12:00 ET
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2019 Results
2020-02-06 12:30 ET
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2019 Earnings Release Date and Conference Call Details
2020-01-13 11:33 ET
Surgery Partners, Inc. Announces Executive Promotions
2020-01-10 22:15 ET
RM LAW Announces Investigation of Surgery Partners, Inc.
2020-01-07 03:31 ET
Surgery Partners, Inc. to Present at Upcoming Investor Conference
2019-11-05 12:00 ET
Surgery Partners, Inc. Announces Third Quarter 2019 Results
2019-10-16 12:00 ET
Surgery Partners, Inc. Announces Third Quarter 2019 Earnings Release Date and Conference Call Details

SEC forms

Show financial reports only

SEC form 10
2024-02-26 16:45 ET
Surgery Partners published news for 2023 q4
SEC form 8
2024-02-26 07:31 ET
Surgery Partners published news for 2023 q4
SEC form 8
2024-02-26 07:31 ET
Surgery Partners reported for 2023 q4
SEC form 10
2024-02-26 00:00 ET
Surgery Partners published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Surgery Partners published news for 2023 q4
SEC form 10
2023-11-07 16:38 ET
Surgery Partners reported for 2023 q3
SEC form 8
2023-11-07 07:34 ET
Surgery Partners reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Surgery Partners published news for 2023 q3
SEC form 10
2023-08-01 16:32 ET
Surgery Partners reported for 2023 q2
SEC form 6
2023-08-01 07:32 ET
Surgery Partners reported for 2023 q2
SEC form 10
2023-08-01 00:00 ET
Surgery Partners published news for 2023 q2
SEC form 8
2023-08-01 00:00 ET
Surgery Partners published news for 2023 q2
SEC form 6
2023-06-07 10:56 ET
Surgery Partners published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
Surgery Partners published news for 2023 q1
SEC form 8
2023-05-01 00:00 ET
Surgery Partners published news for 2023 q1
SEC form 6
2023-03-06 17:47 ET
Surgery Partners published news for 2022 q4
SEC form 10
2023-03-01 09:46 ET
Surgery Partners reported for 2022 q4
SEC form 6
2023-03-01 07:43 ET
Surgery Partners published news for 2022 q4
SEC form 8
2023-03-01 00:00 ET
Surgery Partners reported for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Surgery Partners published news for 2022 q4
SEC form 6
2023-01-09 07:32 ET
Surgery Partners published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Surgery Partners published news for 2022 q4
SEC form 6
2022-12-22 17:27 ET
Surgery Partners published news for 2022 q3
SEC form 6
2022-11-22 16:07 ET
Surgery Partners published news for 2022 q3
SEC form 10
2022-11-08 16:55 ET
Surgery Partners reported for 2022 q3
SEC form 6
2022-11-08 07:41 ET
Surgery Partners published news for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Surgery Partners reported for 2022 q3
SEC form 10
2022-11-08 00:00 ET
Surgery Partners published news for
SEC form 6
2022-11-01 18:20 ET
Surgery Partners published news for 2022 q3
SEC form 10
2022-08-02 16:44 ET
Surgery Partners reported for 2022 q2
SEC form 6
2022-08-02 07:33 ET
Surgery Partners published news for 2022 q2
SEC form 8
2022-08-02 00:00 ET
Surgery Partners reported for 2022 q2
SEC form 10
2022-08-02 00:00 ET
Surgery Partners reported for 2022 q2
SEC form 6
2022-05-20 16:08 ET
Surgery Partners published news for 2022 q1
SEC form 10
2022-05-03 17:16 ET
Surgery Partners reported for 2022 q1
SEC form 6
2022-05-03 07:32 ET
Surgery Partners published news for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Surgery Partners reported for 2022 q1
SEC form 10
2022-05-03 00:00 ET
Surgery Partners reported for 2022 q1
SEC form 6
2022-04-07 16:16 ET
Surgery Partners published news for 2022 q1
SEC form 10
2022-03-01 16:10 ET
Surgery Partners published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Surgery Partners published news for 2021 q4
SEC form 6
2022-02-28 16:13 ET
Surgery Partners published news for 2021 q4
SEC form 8
2022-02-28 00:00 ET
Surgery Partners published news for 2021 q4
SEC form 6
2022-02-03 17:58 ET
Surgery Partners published news for 2021 q4
SEC form 6
2022-02-03 17:58 ET
Surgery Partners published news for 2021 q4
SEC form 6
2022-01-10 07:37 ET
Surgery Partners published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Surgery Partners published news for 2021 q4
SEC form 6
2021-11-22 16:31 ET
Surgery Partners published news for 2021 q3
SEC form 6
2021-11-09 08:30 ET
Surgery Partners published news for 2021 q3
SEC form 10
2021-11-03 07:03 ET
Surgery Partners published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
Surgery Partners published news for 2021 q3
SEC form 6
2021-11-02 16:19 ET
Surgery Partners published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Surgery Partners published news for 2021 q3
SEC form 6
2021-08-17 06:54 ET
Surgery Partners published news for 2021 q2
SEC form 10
2021-08-04 16:21 ET
Surgery Partners published news for 2021 q2
SEC form 6
2021-08-04 07:04 ET
Surgery Partners published news for 2021 q2
SEC form 10
2021-08-04 00:00 ET
Surgery Partners published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
Surgery Partners published news for 2021 q2
SEC form 6
2021-05-28 16:41 ET
Surgery Partners published news for 2021 q1
SEC form 6
2021-05-18 07:13 ET
Surgery Partners published news for 2021 q1
SEC form 10
2021-05-05 16:49 ET
Surgery Partners published news for 2021 q1
SEC form 6
2021-05-05 07:05 ET
Surgery Partners published news for 2021 q1
SEC form 6
2021-05-05 06:01 ET
Surgery Partners published news for 2021 q1
SEC form 10
2021-05-05 00:00 ET
Surgery Partners published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Surgery Partners published news for 2021 q1
SEC form 6
2021-04-20 07:52 ET
Surgery Partners published news for 2021 q1
SEC form 8
2021-04-20 00:00 ET
Surgery Partners published news for 2021 q1
SEC form 6
2021-04-15 16:15 ET
Surgery Partners published news for 2021 q1
SEC form 6
2021-03-15 12:09 ET
Surgery Partners published news for 2020 q4
SEC form 10
2021-03-10 17:22 ET
Surgery Partners published news for 2020 q4
SEC form 6
2021-03-10 07:03 ET
Surgery Partners published news for 2020 q4
SEC form 6
2021-03-01 17:38 ET
Surgery Partners published news for 2020 q4
SEC form 6
2021-01-29 09:28 ET
Surgery Partners published news for 2020 q4
SEC form 6
2021-01-20 15:41 ET
Surgery Partners published news for 2020 q4
SEC form 6
2021-01-20 15:39 ET
Surgery Partners published news for 2020 q4
SEC form 6
2021-01-11 07:31 ET
Surgery Partners published news for 2020 q4
SEC form 10
2020-11-04 16:37 ET
Surgery Partners published news for 2020 q3
SEC form 6
2020-11-04 07:02 ET
Surgery Partners published news for 2020 q3